Mckesson Corp is primarily active in the healthcare and pharmaceutical industries.

The main competitors of Mckesson Corp in the market include Cardinal Health, AmerisourceBergen, and Owens & Minor.

McKesson Corp is a leading global healthcare company that has a rich history and extensive background. Founded in 1833 by John McKesson and Charles Olcott, the company initially operated as a pharmaceutical wholesaler. Over the years, McKesson Corp has expanded its operations and diversified its services. Today, it provides innovative healthcare solutions and advanced technologies to improve patient care and drive efficiency in the industry. With a focus on pharmaceutical distribution, medical supplies, technologies, and healthcare business solutions, McKesson Corp has become a trusted name in the healthcare sector. The company's commitment to delivering quality healthcare solutions has firmly established its position as a key player in the industry.

McKesson Corp, a leading healthcare services and pharmaceutical distribution company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, a prestigious ranking of the largest US corporations. Additionally, McKesson's acquisition of several notable companies, such as Celesio AG and PSS World Medical Inc., have expanded its market presence and strengthened its position in the industry. Furthermore, the company has consistently delivered strong financial performance and demonstrated its commitment to innovation and technological advancements in healthcare. McKesson Corp continues to strive for excellence, making it a reliable and trusted partner in the healthcare sector.

Mckesson Corp is primarily present in the United States.

Mckesson Corp represents a strong set of values and a clear corporate philosophy. The company prioritizes integrity, teamwork, and customer-driven thinking. Mckesson Corp strives for excellence in all its endeavors, placing a strong emphasis on ethical conduct and transparency. With a focus on delivering innovative healthcare solutions, Mckesson Corp aims to improve patient care and drive positive change in the industry. The company's commitment to diversity and inclusion is also evident in its corporate philosophy. Mckesson Corp remains dedicated to providing quality products and services while upholding its core values to benefit both customers and the healthcare community.

Analysts currently set an average price target of 964.44 USD for the McKesson stock (median: 984.81 USD), implying +12.6 % versus the latest price. The consensus is based on 22 analyst ratings.

McKesson Analyst Price Targets 2026

22 analysts currently rate the McKesson stock: 19 recommend buying, 3 holding and 0 selling.

McKesson Analyst Price Targets 2026

Converted at the current exchange rate, the McKesson share trades at 718.55 EUR (827.14 USD).

The McKesson share (MCK) is listed on 7 stock exchanges, including: NYSE (MCK), Frankfurt (MCK.F), München (MCK.MU), Düsseldorf (MCK.DU), London (0JZU.L), London (0JZU.L), SIX (Zürich) (MCK.SW).

Mckesson Corp is a US-based healthcare company that offers a wide range of products and services for the healthcare industry. The company was founded in 1833 as a pharmacy operation and has evolved into a diverse company over the years. Today, Mckesson Corp is one of the largest healthcare companies in the world with an annual revenue of over $231 billion.

The revenue of McKesson is 403.43 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of McKesson is 4.76 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of McKesson is currently 21.31. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the McKesson stock.

The price-to-sales ratio (P/S) of McKesson is currently 0.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the McKesson stock.

The Eulerpool Quality Score for McKesson is 6/10.

The ISIN of McKesson is US58155Q1031. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of McKesson is 893953. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of McKesson is MCK. The ticker symbol is used to trade McKesson shares on the stock exchange.

Over the past 12 months, McKesson paid a dividend of 3.17 USD . This corresponds to a dividend yield of about 0.38 %. For the coming 12 months, McKesson is expected to pay a dividend of 3.60 USD.

The current dividend yield of McKesson is 0.38 %.

McKesson pays a dividend, distributed in the months of , , , .

McKesson paid dividends every year for the past 32 years.

For the upcoming 12 months, dividends amounting to 3.60 USD are expected. This corresponds to a dividend yield of 0.42 %.

McKesson is assigned to the 'Health' sector.

To receive the latest dividend of McKesson from amounting to 0.82 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, McKesson distributed 2.75 USD as dividends.

The dividends of McKesson are distributed in USD.